Private equity’s challenges in healthcare are not rooted in efficiency itself, but in capital structures and incentives that misprice labor. This follow-on to The People Moat explores why cutting clinicians may boost margins briefly — yet quietly erode the foundations of long-term value creation.

Private equity often fails not because it seeks efficiency, but because its capital structures, time horizons, and incentives are misaligned with how companies actually create value. When financial models prioritize short-term margin extraction over the operational realities of care delivery, value destruction is not accidental — it is structural.

This misalignment is especially visible in healthcare. Private equity has become one of the most powerful owners in the U.S. healthcare system, shaping how care is delivered, how clinicians work, and how healthcare labor markets function. In many cases, PE ownership has brought order to fragmented sectors, improved access to capital, and professionalized management. In others, it has exposed a fundamental contradiction between short-term financial optimization and the long-term realities of providing care.

That contradiction is becoming harder to ignore. A growing body of evidence suggests that aggressive short-term efficiency strategies — particularly those focused on cutting labor costs — can undermine clinical quality, destabilize the workforce, and erode long-term enterprise value. Healthcare firms that intentionally build workforce resilience while simplifying operations tend to outperform their peers over time. Labor’s central role in healthcare value creation is no longer in doubt. The question is whether prevailing private equity models are structured to preserve that value — or sacrifice it for short-term gain.

The limits of short-term efficiency in healthcare

Healthcare is uniquely sensitive to staffing decisions. Human judgment at the point of care determines clinical outcomes, patient experience, regulatory compliance, and revenue integrity. Yet many private equity playbooks continue to treat labor primarily as a cost center. Cutting staff, raising productivity targets, and putting pressure on pay can all boost EBITDA in the short term — but they also introduce latent risks that compound over time and are difficult to unwind once embedded.

When financial logic and clinical reality are separated, short-term optimization can quietly undermine long-term value creation.

Research reinforces this dynamic. A Harvard Business Review analysis found that cost-cutting strategies that degrade service quality often undermine long-term performance, even when margins initially improve. In healthcare, these effects are amplified. High clinician turnover makes it harder to deliver consistent care, increases malpractice risk, and drives up recruiting and training costs. National Bureau of Economic Research studies show that higher turnover is directly associated with lower productivity and weaker performance in service-intensive industries.

These costs rarely appear clearly in transaction models. Instead, they surface later as quality failures, regulatory scrutiny, clinician burnout, and reputational damage — risks that become systemic once they take hold.

What healthcare private equity case studies reveal

These dynamics are visible across several high-profile healthcare investments. Physician staffing firms such as Envision Healthcare pursued rapid growth and short-term profitability under heavy leverage, only to encounter operational strain and mounting debt that ultimately led to bankruptcy. While multiple factors were involved, public reporting consistently pointed to clinician dissatisfaction, staffing instability, and payer conflicts as sources of fragility.

Hospital systems such as Steward Health Care, which received private equity backing during periods of expansion, faced criticism for financial engineering that constrained reinvestment in staff and facilities, limiting operational resilience. These cases do not inherently condemn private equity. Rather, they illustrate what happens when financing structures and time horizons exceed the operational realities of healthcare delivery.

Stable care teams are not interchangeable inputs; they are cumulative assets that shape quality, trust, and system performance.

In contrast, private-equity-backed primary care and value-based care platforms that prioritized clinician retention, manageable panel sizes, and care-team support — such as Oak Street Health prior to its acquisition — demonstrated stronger performance. Their economics depended less on labor compression and more on simplifying workflows, improving coordination, and enabling clinicians to practice more effectively. Productivity gains were structural, not extractive.

Reframing labor as a clinical and financial resource

A stakeholder-aligned private equity model in healthcare begins with a fundamental redefinition: clinicians and frontline workers are not interchangeable inputs, but cumulative assets. Retained clinicians build patient trust, reduce unnecessary utilization, improve documentation accuracy, and manage chronic conditions more effectively. Stable care teams detect errors earlier, coordinate care better, and reduce system leakage.

Trust, reputation, clinical capability, and workforce stability compound over years, not quarters.

The OECD has documented strong links among job quality, productivity, and the resilience of healthcare and social service systems. Yet traditional private equity underwriting often treats workforce instability as an operational inconvenience rather than a structural threat. A longer-term model would explicitly account for the cost of maintaining workforce stability in valuation assumptions. Chronic turnover would be understood as a risk to be addressed — akin to customer concentration or outdated infrastructure — not merely a lever for short-term savings.

Operational discipline before reinvesting in labor

Stakeholder alignment does not mean indiscriminately raising wages or headcount. In healthcare, as in other sectors, investment in labor pays off only when paired with operational simplification. Excessive paperwork, fragmented IT systems, misaligned incentives, and poor scheduling waste clinicians’ time and accelerate burnout.

Research from MIT Sloan’s “good jobs strategy” underscores this point: companies must simplify work before investing more heavily in workers if they want those investments to generate returns. In healthcare, this includes interoperable systems, streamlined service lines, team-based care models, and administrative support that allows clinicians to work at the top of their license. Private equity owners are well positioned to drive this kind of systems change — but only if their time horizons allow operational investments to mature.

Time horizons that match care delivery

Healthcare returns build incrementally. Trust, reputation, clinical capability, and workforce stability compound over years, not quarters. A private equity model aligned with these dynamics may require longer holding periods or liquidity structures that avoid forcing exits before operational improvements take hold.

Capital decisions made adjacent to care delivery — but disconnected from it — reveal how labor is routinely mispriced in healthcare.

Evergreen and permanent-capital vehicles are gaining traction precisely because they allow investors to benefit from long-term value creation. Even within traditional fund structures, staged exits or minority recapitalizations can preserve gains while sustaining operational continuity. Unlike many asset classes, healthcare rewards patience. Short-term margin extraction often collides with regulatory cycles, payer contracting timelines, and labor dynamics that cannot be accelerated without consequences.

Governance that reflects clinical reality

Governance is another critical lever. Boards of private-equity-backed healthcare organizations are often dominated by financial professionals, while leaders with deep experience in clinical operations and workforce dynamics remain underrepresented. Excluding medical leadership from governance introduces blind spots that financial oversight alone cannot resolve.

A private equity strategy aligned with stakeholders does not abandon financial discipline.

McKinsey research shows that companies integrating both talent and operational metrics into board oversight outperform peers over the long term. In healthcare, this broader lens helps prevent decisions that may boost near-term financial performance while degrading care quality and workforce stability, such as unsafe staffing ratios or underinvestment in support roles.

Incentives that reward durability, not extraction

Incentive design completes the picture. When executive compensation is tied primarily to short-term EBITDA or rapid equity vesting, management is rewarded for actions that boost near-term results — even if those actions weaken clinical quality or destabilize the workforce. Longer vesting periods and multi-year performance metrics encourage investment in clinician retention, training, and operational reliability.

Research summarized by the Harvard Law School Forum on Corporate Governance shows that longer equity vesting is associated with lower earnings volatility and greater investment in human capital. For sponsors, carried-interest structures that reward steady cash flow rather than exit multiples alone can better balance risk and return. In healthcare, downside protection — regulatory compliance, clinician stability, payer trust — often matters more than marginal gains in valuation.

What healthcare markets still misprice

Despite growing evidence, healthcare markets continue to underprice labor-related risk. Burnout, turnover, and care fragmentation are treated as background conditions rather than determinants of equity performance. The benefits of stable care teams — improved outcomes, reduced utilization, stronger payer relationships — remain difficult to quantify and therefore undervalued.

Analysis from the Brookings Institution during the COVID-19 pandemic highlighted how job quality directly affected system resilience under stress. This mispricing creates opportunity for investors willing to take a longer view: acquire assets weakened by short-term optimization, rebuild their operational foundations, and exit into markets increasingly attentive to quality, predictability, and trust.

A shift in private equity’s role in healthcare

A private equity strategy aligned with stakeholders does not abandon financial discipline. It strengthens it. In healthcare, durable value creation depends on aligning capital structures, incentives, and governance with the realities of care delivery and the people who provide it.

Private equity can deliver strong returns by taking a longer view, investing in operating systems before cutting jobs, and recognizing clinicians as assets rather than costs. This is not a moral argument; it is a practical one. In healthcare, the fastest way to destroy value is to optimize for the short term without accounting for clinical reality. Building resilient, trustworthy organizations is harder — but it is also what lasts, and what ultimately pays off for investors.